Abstract:A unique perspective are proposed with a particular focus on aggregation effects and their impact on reactive oxygen species generation to optimize and manipulate photodynamic therapy efficacy. Comparison between isolated state and nano‐aggregated state as well as differences between various nano‐aggregate states will be introduced and commented through some typical cases. Aggregate‐level photodynamic therapy (PDT) has attracted significant interest and driven substantial advances in multifunction phototheranostic platforms. As exemplified by two typical instances of aggregation‐caused quenching of reactive oxygen species (ROS) and aggregation‐induced generation of ROS, the aggregation effect plays a significant role on the ROS generation of photosensitizers (PSs), which is worthy of in‐depth exploration and full utilization. However, in contrast to the well‐developed researches on the aggregation effect on luminescence, the studies concerning the aggregation effect on ROS generation are currently in a relatively nascent and disjointed stage, lacking guidance from a firmly established research paradigm. To advance this regard, this review aims at providing a consolidated overview of the fundamental principles and research status of aggregation effects on the ROS generation. Here, the research status can be organized into two main facets. One involves the comparison between isolated state and aggregated state, which is mainly conducted by two methods of changing solvent environments and adding adjuvants into a given solvent. The other underscores the distinctions between different aggregate states, consisting of three parts, namely comparison within the same or between different categories based on the classification of single‐component and multicomponent aggregates. In this endeavor, we will present our views on current research methodologies that explore how aggregation affects ROS generation and highlight the design strategies to leverage the aggregation effect to optimize PS regiments. We aspire this review to propel the advancement of phototheranostic platforms and accelerate the clinical implementation of precision medicine, and inspire more contributions to aggregate‐level photophysics and photochemistry, pushing the aggregate science and materials forward.

Aggregation-Induced Generation of Reactive Oxygen Species: Mechanism and Photosensitizer Construction.

AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy

Aggregation-Induced Emission Luminogens for Enhanced Photodynamic Therapy: from Organelle Targeting to Tumor Targeting

Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy

A feasible molecular engineering for bright Π-conjugation free radical photosensitizers with aggregation-induced emission

Intracellularly Manipulable Aggregation of the Aggregation-Induced Emission Luminogens

Aggregation‐Induced Emission Luminogens with Photoresponsive Behaviors for Biomedical Applications

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Emerging Designs of Aggregation-Induced Emission Agents for Enhanced Phototherapy Applications

Molecular engineering to enhance the reactive oxygen species generation of AIEgens and exploration of their versatile applications

Utilizing a Pyrazine-Containing Aggregation-Induced Emission Luminogen As an Efficient Photosensitizer for Imaging-Guided Two-Photon Photodynamic Therapy.

Recent advances in aggregation-induced emission-active type I photosensitizers with near-infrared fluorescence: From materials design to therapeutic platform fabrication

Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical

A Feasible Strategy of Fabricating Type I Photosensitizer for Photodynamic Therapy in Cancer Cells and Pathogens

Structure and functions of Aggregation-Induced Emission-Photosensitizers in anticancer and antimicrobial theranostics

Molecular Engineering to Boost AIE‐Active Free Radical Photogenerators and Enable High‐Performance Photodynamic Therapy under Hypoxia

Aggregation-Induced Emission Photosensitizer with Ag(I)-π Interaction-Enhanced Reactive Oxygen Species for Eliminating Multidrug Resistant Bacteria

Mechanism research of type I reactive oxygen species conversion based on molecular and aggregate levels for tumor photodynamic therapy

Exploring and leveraging aggregation effects on reactive oxygen species generation in photodynamic therapy

Enhancing the Operability of Photoexcitation-Controlled Aggregation-Induced Emissive Molecules in the Organic Phase.

An AIE Photosensitizer with Simultaneous Type I and Type II ROS Generation: Efficient Bacterial Elimination and Hypoxic Tumor Ablation